Alport Syndrome Market is Driven by Gene Therapy Advances

ha aggiunto una foto Health

2025-05-08 12:54:01 -

Alport syndrome is a rare progressive renal disease characterized by inherited defects in type IV collagen, leading to hematuria, proteinuria and eventual kidney failure. The Alport Syndrome Market comprises a diverse portfolio of therapeutics, including symptomatic treatments such as ACE inhibitors, emerging small molecules, biologics targeting fibrosis pathways and novel gene therapies...

0 Commenti 0 condivisioni 657 Views 0 Anteprima